Determination of rivaroxaban – a novel, oral, direct Factor Xa inhibitor – in human plasma by high-performance liquid chromatography–tandem mass spectrometry-Reference-Cited by-同舟云学术

Determination of rivaroxaban – a novel, oral, direct Factor Xa inhibitor – in human plasma by high-performance liquid chromatography–tandem mass spectrometry

Published:2008-09 Issue:1-2 Volume:872 Page:43-50
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Rohde G.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference15 articles.

1. What is all that thrombin for?

2. Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor

3. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939) – an oral, direct factor Xa inhibitor

4. Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures;Cardiovascular Drugs and Therapy;2024-03-20

2. Spectrophotometric resolution for quantitative analysis of aspirin and rivaroxaban combination therapy in biological fluids using simple and eco-friendly procedure;BMC Chemistry;2024-02-19

3. A comparative in vitro study of the anticoagulant effect of branded versus generic rivaroxaban;Thrombosis Research;2024-01

4. Association of direct oral anticoagulant and delayed bleeding with pharmacokinetics after endoscopic submucosal dissection;Gastrointestinal Endoscopy;2023-12

5. Development and validation of a stability-indicating RP-HPLC method for the determination of fifteen impurities in rivaroxaban;Journal of Pharmaceutical and Biomedical Analysis;2023-05